Literature DB >> 7525631

The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.

L C Giudice1, B A Dsupin, S E Gargosky, R G Rosenfeld, J C Irwin.   

Abstract

Peritoneal fluid (PF) lines the abdomen and pelvis and is believed to contain growth factors that stimulate endometriosis, a benign gynecological condition associated with pelvic pain and infertility, in which endometrial cells proliferate and differentiate on the pelvic peritoneum, outside of their normal location within the uterus. In this study, we examined the insulin-like growth factor (IGF) system in seven paired samples of PF and serum from normally cycling women and examined the mitogenic potential of this fluid on cultured endometrial stromal cells. IGF-I, IGF-II, and IGF-binding protein-1 (IGFBP-1), -2, -3, and -4 were identified in PF by immunoassays. PF IGF levels, determined by RIA, were approximately 60% of paired serum levels, and PF levels of IGFBP-2 and IGFBP-3, determined by Western ligand blotting and RIA, respectively, were approximately half of their serum concentrations. IGFBP-4 was barely detectable by Western ligand blotting in PF, and levels of IGFBP-1, determined by immunoassay, were not appreciably different in PF and serum. Incubation of [125I]IGF-II with serum and PF and subsequent size-exclusion chromatography at neutral pH revealed approximately equal incorporation of radiolabel in the IGFBP regions of 150 and 44 kilodaltons (kDa) in serum and primarily in the 44-kDa region in PF. RIA of IGFBP-3 in the IGFBP regions of column effluent revealed that the majority of IGFBP-3 was in the 150-kDa region in both serum and PF, suggesting the presence of the ternary complex in PF. Western ligand blotting of column effluent samples revealed 37-/43-kDa IGFBP-3 primarily in the 150-kDa complex in serum and a marked reduction in the amount of the 37-/43-kDa IGFBP in PF. Western immunoblotting of column effluent with IGFBP-3 antiserum revealed immunoreactive IGFBP-3 forms of 37-43 kDa (major) and 28 kDa (minor) in serum and almost exclusively the 28-kDa band in PF, suggesting that IGFBP-3 in PF may be proteolytically processed. The presence of an IGFBP-3 protease was confirmed using [125I]IGFBP-3 as substrate and was not appreciably present in paired serum samples. Inhibitor profiles demonstrated that this protease is a metal-independent serine protease, and its approximate relative molecular mass was estimated to be 69 kDa, determined by size-exclusion chromatography. The mitogenic potential of IGF peptides and PF was assessed on cultured endometrial stromal cells to test the hypothesis that IGFs in PF may stimulate the growth of endometrium in the pelvic cavity, for example in the disorder of endometriosis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525631     DOI: 10.1210/jcem.79.5.7525631

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model.

Authors:  A Zeitvogel; R Baumann; A Starzinski-Powitz
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 2.  Pathogenesis and pathophysiology of endometriosis.

Authors:  Richard O Burney; Linda C Giudice
Journal:  Fertil Steril       Date:  2012-07-20       Impact factor: 7.329

3.  Associations among body size across the life course, adult height and endometriosis.

Authors:  L V Farland; S A Missmer; A Bijon; G Gusto; A Gelot; F Clavel-Chapelon; S Mesrine; M C Boutron-Ruault; M Kvaskoff
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918

4.  A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis.

Authors:  Fan Mu; Susan E Hankinson; Eva Schernhammer; Michael N Pollak; Stacey A Missmer
Journal:  Am J Epidemiol       Date:  2015-06-28       Impact factor: 4.897

5.  IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.

Authors:  Yan Zhou; Cheng Zeng; Xin Li; Pei-Li Wu; Ling Yin; Xiao-Lan Yu; Ying-Fang Zhou; Qing Xue
Journal:  J Mol Med (Berl)       Date:  2016-02-22       Impact factor: 4.599

Review 6.  Roles of CLR/RAMP receptor signaling in reproduction and development.

Authors:  Chia Lin Chang; Sheau Yu Teddy Hsu
Journal:  Curr Protein Pept Sci       Date:  2013-08       Impact factor: 3.272

7.  Insulin signaling is an essential regulator of endometrial proliferation and implantation in mice.

Authors:  Nikola Sekulovski; Allison E Whorton; Mingxin Shi; Kanako Hayashi; James A MacLean
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

8.  Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls.

Authors:  Sahel Heidari; Roya Kolahdouz-Mohammadi; Sepideh Khodaverdi; Nader Tajik; Ali-Akbar Delbandi
Journal:  BMC Womens Health       Date:  2021-12-20       Impact factor: 2.809

9.  Effect of octreotide on endometriosis in acromegaly: Case report with review of literature.

Authors:  Seerat Singh; Aditi Anupam Chakravarty; Smita Manchanda; Renuka Mallik; Shweta Chopra; Ajay Ajmani; Bindu Kulshreshtha
Journal:  Indian J Endocrinol Metab       Date:  2014-03

Review 10.  Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies.

Authors:  Yi-Heng Lin; Ya-Hsin Chen; Heng-Yu Chang; Heng-Kien Au; Chii-Ruey Tzeng; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2018-08-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.